Impact of adrenal versus ovarian androgen ratio on signs and symptoms of polycystic ovarian syndrome

Author： Köşüş Nermin   Köşüş Aydın   Kamalak Zeynep   Hızlı Deniz   Turhan Nilgün Ö  

Publisher： Informa Healthcare

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.28, Iss.8, 2012-08, pp. : 611-614

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Polycystic ovarian syndrome in adolescence

By Yii Ming Fong   Lim Chi Eung Danforn   Luo Xiping   Wong Wu Shun Felix   Cheng Nga Chong Lisa   Zhan Xinlin  

Gynecological Endocrinology, Vol. 25, Iss. 10, 2009-10 ,pp. : 634-639

Informa Healthcare

Access to resources Recommend Favorite

What is polycystic ovarian syndrome?

By Homburg Roy  

Human Reproduction, Vol. 17, Iss. 10, 2002-10 ,pp. : 2495-2499

Oxford University Press

Access to resources Recommend Favorite

In-vivo ovarian androgen responses to recombinant FSH with and without recombinant LH in polycystic ovarian syndrome

By Cheung Anthony P.  

Human Reproduction, Vol. 17, Iss. 10, 2002-10 ,pp. : 2540-2547

Oxford University Press

Access to resources Recommend Favorite

The role of cytokines in polycystic ovarian syndrome

By Ebejer Krystle   Calleja-Agius Jean  

Gynecological Endocrinology, Vol. 29, Iss. 6, 2013-06 ,pp. : 536-540

Informa Healthcare

Access to resources Recommend Favorite

Diagnostic criteria for polycystic ovarian syndrome

By Broekmans F.   Fauser B.  

Endocrine Journal, Vol. 30, Iss. 1, 2006-08 ,pp. : 3-11

Humana Press, Inc

Access to resources Recommend Favorite